MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, GYRE made $30,564K in revenue. $3,610K in net income. Net profit margin of 11.81%.

Income Overview

Revenue
$30,564K
Net Income
$3,610K
Net Profit Margin
11.81%
EPS
$0.03
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-09-30
Revenues
30,564 -25,488
Cost of revenues
1,628 -958
Selling and marketing
15,328 -13,699
Research and development
2,363 -2,775
General and administrative
4,319 -3,823
Loss on disposal of assets, net
-1 --
Total operating expenses
23,639 -21,255
Income from operations
6,925 -4,233
Change in fair value of warrant liability
23 -228
Interest income, net
--523
Other income (expense), net
727 --598
Income before income taxes
7,629 -3,930
Provision for income taxes
1,693 -1,074
Net income
5,936 1,576 2,856
Other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to parent, total
-303 -
Comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest
-1,879 -
Other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax, portion attributable to noncontrolling interest
-104 -
Net income attributable to noncontrolling interest
2,326 1,134 1,732
Comprehensive income (loss), net of tax, attributable to noncontrolling interest
-1,238 -
Comprehensive income (loss), net of tax, attributable to parent
-641 -
Net income attributable to common stockholders
3,610 -1,124
Earnings per share, basic
0.04 0 0.01
Earnings per share, diluted
0.03 0 0.01
Weighted average number of shares outstanding, diluted
103,971,546 102,701,707 102,640,373
Weighted-average number of shares used in computing net income (loss) per share available to common stockholders, basic
90,850,040 89,119,344 85,643,646
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Revenues$30,564K Other income(expense), net$727K Income from operations$6,925K Total operatingexpenses$23,639K Income before incometaxes$7,629K Change in fair value ofwarrant liability$23K Loss on disposal ofassets, net-$1K General andadministrative$4,319K Research and development$2,363K Selling and marketing$15,328K Cost of revenues$1,628K Net income$5,936K Provision for income taxes$1,693K Net incomeattributable to common...$3,610K Net incomeattributable to...$2,326K

GYRE THERAPEUTICS, INC. (GYRE)

GYRE THERAPEUTICS, INC. (GYRE)